BiotechDispatch - Biotech

Latest News

Brandon Capital backs New Zealand immunotherapy start-up
May 25, 2022
AusBiotech

Thriving medtech community celebrated at record-breaking AusMedtech 2022
May 26, 2022
Latest News

Archer Materials secures Australian patent for quantum computing chip
May 24, 2022

Latest News Anteris Technologies expands its medical advisory board May 25, 2022
Anteris Technologies (ASX:AVR) has announced the appointment of Associate Professor Dion Stub of the Alfred Hospital and Monash University to its Australian medical advisory board.
New clinical trial to test cancer drug in motor neuron disease May 24, 2022
PharmAust (ASX:PAA) is launching a Phase 1 clinical trial of monepantel for the treatment of motor neuron disease or Amyotrophic Lateral Sclerosis.
Latest News New government starts work on key election commitments May 24, 2022
Labor's interim ministry has started work on key election commitments including its planned Budget and the major boost for medical manufacturing.
AusBiotech AusBiotech welcomes incoming federal government May 24, 2022
AusBiotech welcomes the 31st Australian government and extends its congratulations to incoming ministers and elected members of parliament.
Latest News 4DMedical appoints director to executive position May 24, 2022
Respiratory imaging technology company 4DMedical (ASX:4DX) has announced that director John Livingston has been appointed to an executive position with the company.
Latest News Living Cell Technologies announces new agreement to use AI in trial May 24, 2022
Living Cell Technologies (ASX:LCT) says artificial intelligence will be applied to its research into Parkinson’s disease under a new agreement with OptiCellAI.
Latest News MCIA releases roadmap to growth for the Australian medicinal cannabis industry May 24, 2022
Medicinal Cannabis Industry Australia has released a roadmap it hopes will provide the vision and way forward for the sector's growth in Australia.
Latest News Starpharma says SPL7013 in VIRALEZE virucidal against influenza A and B May 18, 2022
Starpharma (ASX:SPL) says SPL7013, the antiviral agent in VIRALEZE nasal spray, achieved 95 per cent and 99.7 per cent reduction in viral infectivity against two significant types of influenza virus, A and B, respectively, in virucidal assays.
Latest News Immutep appoints leading oncologists to clinical advisory board May 18, 2022
Immutep (ASX:IMM) has announced the appointment of four new members to its Clinical Advisory Board.
AusBiotech Celebrating industry leaders on International Clinical Trials Day May 19, 2022
AusBiotech is delighted to be presenting the inaugural Industry Partnership Award at the 2022 ACTA National Tribute and Awards Ceremony in Sydney, which coincides with the celebration of International Clinical Trials Day on 20 May.
Latest News FDA confirms a diagnostic method for Medibio’s final depression validation trial May 19, 2022
Medibio (ASX:MEB) has announced that a DSM-V 1 diagnosis will be included as a primary comparator for the purposes of assessing the efficacy of its depression algorithms, MEB-001.
Latest News AnteoTech's updated COVID-19 RAT receives regulatory approval in Europe May 19, 2022
AnteoTech (ASX:ADO) has registered an updated EuGeni COVID-19 Rapid Antigen Test in Europe under the In Vitro Diagnostic Directive 98/79/EC Regulations.
Latest News PharmAust says MPL tablets arrive for Motor Neuron Disease trial May 17, 2022
PharmAust (ASX:PAA) has announced the arrival of its cGMP grade monepantel tablets specifically designed for the MND trial in Melbourne.
AusBiotech Help the AusBiotech 2022 programme ‘Come Alive’ May 17, 2022
AusBiotech is calling for session proposals and speakers for Australia’s largest life sciences event of the year - AusBiotech 2022, to be held 26 - 28 October in Perth.
Latest News Illumina's Susan Tousi on genomics and changing healthcare May 17, 2022
Illumina's global chief commercial officer Susan Tousi believes genomics will be a significant factor in the accelerated development of targeted therapies.
Latest News 4DMedical COPD trial results presented at US lung conference May 17, 2022
Respiratory imaging technology company 4DMedical (ASX:4DX) has announced the presentation of findings of its COPD clinical trial undertaken at Johns Hopkins University Hospital in the US.
Latest News Nyrada says European patent to be granted for cholesterol-lowering drug May 17, 2022
Nyrada (ASX:NYR) says the European Patent Office has issued a Notice of Intention to grant the company’s patent application number EP18768188.7.

Most Read

New Stories